GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » E10

Biocon (NSE:BIOCON) E10 : ₹6.92 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Biocon E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biocon's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹1.130. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹6.92 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Biocon's average E10 Growth Rate was 8.30% per year. During the past 3 years, the average E10 Growth Rate was -17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biocon was -17.40% per year. The lowest was -34.60% per year. And the median was -26.00% per year.

As of today (2024-06-06), Biocon's current stock price is ₹305.25. Biocon's E10 for the quarter that ended in Mar. 2024 was ₹6.92. Biocon's Shiller PE Ratio of today is 44.11.

During the past 13 years, the highest Shiller PE Ratio of Biocon was 63.84. The lowest was 8.38. And the median was 37.77.


Biocon E10 Historical Data

The historical data trend for Biocon's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon E10 Chart

Biocon Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.80 12.27 6.40 6.39 6.92

Biocon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.39 6.48 6.50 6.96 6.92

Competitive Comparison of Biocon's E10

For the Biotechnology subindustry, Biocon's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocon's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocon's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biocon's Shiller PE Ratio falls into.



Biocon E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biocon's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.13/153.0345*153.0345
=1.130

Current CPI (Mar. 2024) = 153.0345.

Biocon Quarterly Data

per share eps CPI Adj_EPS
201406 0.867 94.103 1.410
201409 0.853 96.780 1.349
201412 0.760 96.780 1.202
201503 1.633 97.163 2.572
201506 1.050 99.841 1.609
201509 -0.090 101.753 -0.135
201512 0.883 102.901 1.313
201603 2.825 102.518 4.217
201606 1.410 105.961 2.036
201609 1.235 105.961 1.784
201612 1.440 105.196 2.095
201703 1.070 105.196 1.557
201706 0.685 107.109 0.979
201709 0.580 109.021 0.814
201712 0.775 109.404 1.084
201803 1.095 109.786 1.526
201806 1.010 111.317 1.389
201809 2.980 115.142 3.961
201812 1.820 115.142 2.419
201903 1.790 118.202 2.317
201906 1.740 120.880 2.203
201909 1.820 123.175 2.261
201912 1.710 126.235 2.073
202003 1.030 124.705 1.264
202006 1.250 127.000 1.506
202009 1.410 130.118 1.658
202012 1.400 130.889 1.637
202103 2.120 131.771 2.462
202106 0.710 134.084 0.810
202109 1.160 135.847 1.307
202112 1.560 138.161 1.728
202203 1.990 138.822 2.194
202206 1.210 142.347 1.301
202209 0.390 144.661 0.413
202212 -0.350 145.763 -0.367
202303 2.620 146.865 2.730
202306 0.850 150.280 0.866
202309 1.050 151.492 1.061
202312 5.510 152.924 5.514
202403 1.130 153.035 1.130

Add all the adjusted EPS together and divide 10 will get our e10.


Biocon  (NSE:BIOCON) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biocon's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=305.25/6.92
=44.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Biocon was 63.84. The lowest was 8.38. And the median was 37.77.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biocon E10 Related Terms

Thank you for viewing the detailed overview of Biocon's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocon (NSE:BIOCON) Business Description

Traded in Other Exchanges
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (NSE:BIOCON) Headlines

No Headlines